You have 9 free searches left this month | to do more
Showing 1 - 25 of
1,224 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
I
The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma
Active, not recruiting
  • Sarcoma, Ewing
  • patients
  • Bologna, Italy
    Istituto Ortopedico Rizzoli
2022-03-25
Mar 25, 2022
D
Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors - 2020
Terminated
Has Results
  • Ewing Sarcoma
  • +10 more
  • Stereotactic Body Radiotherapy (SBRT)
  • Boston, Massachusetts
  • +2 more
2021-04-05
Apr 5, 2021
S
Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas
Recruiting
  • Sarcoma, Bone
  • +5 more
  • Diffusion Weighted Magnetic Resonance Imaging
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
2022-01-07
Jan 7, 2022
M
A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma or Ewing-Like Sarcoma
Recruiting
  • Ewing Sarcoma
  • Ewing-Like Sarcoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
2022-03-02
Mar 2, 2022
N
Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
Not yet recruiting
  • Sarcoma, Ewing
  • Rhabdomyosarcoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
O
TK216 in Patients With Relapsed or Refractory Ewing Sarcoma
Recruiting
  • Sarcoma, Ewing
  • Los Angeles, California
  • +8 more
2021-11-19
Nov 19, 2021
I
Study of Blood Samples From Patients With Ewing Sarcoma and Their Relatives - 2019
Completed
  • Sarcoma
  • genome-wide association study
  • Paris, France
    Institut Curie Hopital
2021-05-18
May 18, 2021
D
Cabozantinib With Topotecan-Cyclophosphamide
Recruiting
  • Relapsed Ewing Sarcoma
  • +3 more
  • Boston, Massachusetts
  • +1 more
2021-09-27
Sep 27, 2021
S
A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma
Not yet recruiting
  • Sarcoma, Ewing
  • TK216+Vincristin
  • Beijing, Beijing, China
  • +7 more
2022-03-28
Mar 28, 2022
M
Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma
Withdrawn
  • Metastatic Ewing Sarcoma
  • Recurrent Ewing Sarcoma
  • Fine-Needle Aspiration
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-01
Feb 1, 2022
D
Palbociclib + Ganitumab In Ewing Sarcoma
Active, not recruiting
  • Ewing Sarcoma
  • Ewing's Sarcoma Recurrent
  • Boston, Massachusetts
  • +2 more
2022-03-21
Mar 21, 2022
W
Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors
Recruiting
  • Glioma
  • +6 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-09-22
Sep 22, 2021
V
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
Recruiting
  • Solid Tumors
  • +5 more
  • Durham, North Carolina
  • +1 more
2021-10-26
Oct 26, 2021
G
Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma
Active, not recruiting
  • Tumor, Desmoplastic Small Round Cell, Adult
  • +4 more
  • nab paclitaxel
  • Barcelona, Spain
  • +6 more
2021-02-05
Feb 5, 2021
S
SM-88 as Maintenance Therapy for Advanced Ewing's Sarcoma Patients and as Salvage Therapy for Sarcoma Patients
Recruiting
  • Sarcoma, Ewing
  • Sarcoma
  • Combination metyrosine-derivative, low-dose methoxsalen, phenytoin and sirolimus (MPS)
  • Santa Monica, California
    Sarcoma Oncology Research Center
2021-03-26
Mar 26, 2021
F
Drug Sensitivity and Mutation Profiling
Recruiting
  • Ewing Sarcoma
  • +6 more
    • Miami, Florida
      Nicklaus Children's Hospital
    2021-06-30
    Jun 30, 2021
    A
    Ewing Sarcoma Family of Tumors (ESFT): A 15-year Experience From a Tertiary Care Cancer Center in Upper Egypt - 2020
    Completed
    • Soft Tissue Neoplasms
    • +2 more
      • Assiut, Egypt
        South Egypt Cancer Institute
      2020-12-16
      Dec 16, 2020
      M
      Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma
      Recruiting
      • Ewing Sarcoma
      • Rhabdomyosarcoma
      • Boston, Massachusetts
      • +4 more
      2021-10-27
      Oct 27, 2021
      S
      Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers - 2021
      Completed
      • Ewing Sarcoma
      • +13 more
      • Santa Monica, California
        Sarcoma Oncology Research Center
      2021-12-02
      Dec 2, 2021
      I
      Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse
      Recruiting
      • Osteosarcoma
      • Ewing Sarcoma
      • Metformin Hydrochloride
      • Bologna, Italy
        Chemotherapy Div, Istituto Ortopedico Rizzoli
      2021-03-28
      Mar 28, 2021
      U
      Early Ageing During Therapy in AYA Cancer Patients
      Not yet recruiting
      • Cancer
      • +7 more
      • Blood sampling
      • Groningen, Netherlands
        University Medical Center Groningen
      2022-01-04
      Jan 4, 2022
      B
      Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma
      Withdrawn
      • Soft Tissue Sarcoma
      • +12 more
      • Providence, Rhode Island
      • +1 more
      2021-11-30
      Nov 30, 2021
      N
      Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma
      Active, not recruiting
      Has Results
      • Metastatic Ewing Sarcoma
      • +9 more
      • Cabozantinib S-malate
      • Laboratory Biomarker Analysis
      • Bordeaux, France
      • +10 more
      2021-11-09
      Nov 9, 2021
      S
      Radiation Therapy to Treat Musculoskeletal Tumors
      Active, not recruiting
      • Sarcoma, Ewing's
      • +3 more
      • image-guided radiotherapy
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      2022-04-04
      Apr 4, 2022
      S
      A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)
      Enrolling by invitation
      • Ewing Sarcoma
      • +8 more
      • Santa Monica, California
        Sarcoma Oncology Center
      2022-02-23
      Feb 23, 2022